Controlled ingrowth feature for antimigration

US11590008B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11590008-B2
Application numberUS-201916263353-A
CountryUS
Kind codeB2
Filing dateJan 31, 2019
Priority dateOct 2, 2014
Publication dateFeb 28, 2023
Grant dateFeb 28, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A tubular prosthesis that includes a scaffolding formed by at least one scaffolding filament; a cover; and at least one controlled ingrowth feature constructed and arranged to abut an inner surface of a lumen wall when the prosthesis is implanted in the body lumen. The controlled ingrowth feature may extend inwards or outwards from the prosthesis outer surface. The controlled ingrowth feature may be formed by a scaffolding filament; by a separate filament; by the cover; and combinations thereof.

First claim

Opening claim text (preview).

What is claimed is: 1. A stent comprising: a tubular scaffolding formed by at least one interwoven filament, the tubular scaffolding expandable from a compressed delivery state to an expanded implanted state, the scaffolding extending between first and second ends of the stent, the scaffolding having an outer surface and an inner surface, the inner surface defining a lumen of the tubular scaffolding, wherein the at least one interwoven filament of the scaffolding defines a plurality of openings between filament crossings of the at least one interwoven filament, the plurality of openings extending between the inner and outer surfaces; and a cover disposed on the scaffolding, the stent including a first portion in which the cover covers and contacts at least one of the inner and outer surfaces of the scaffolding, and a second portion in which a radially outward surface of a section of the cover extends inward of the scaffolding and is spaced radially inward away from the inner surface of the scaffolding to define a void between the radially outward surface of the cover and the inner surface of the scaffolding, thereby creating a controlled tissue ingrowth feature within the openings, wherein the scaffolding has a constant outer diameter throughout the first and second portions. 2. The stent of claim 1 , wherein the controlled tissue ingrowth feature is formed only by the cover. 3. The stent of claim 1 , wherein in the first portion of the stent, the cover covers only the outer surface of the scaffolding. 4. The stent of claim 3 , wherein an outer surface of the stent is defined only by the cover. 5. The stent of claim 1 , wherein the first and second portions alternate along a length of the stent. 6. The stent of claim 1 , wherein in the first portion of the stent, the cover covers both the inner and outer surfaces of the scaffolding. 7. The stent of claim 1 , wherein the section of the cover defining the controlled tissue ingrowth feature spans a single scaffold opening. 8. The stent of claim 7 , wherein the single scaffold opening has a size greater than scaffold openings in the first portion of the stent. 9. The stent of claim 1 , wherein the section of the cover defining the controlled tissue ingrowth feature spans a plurality of scaffold openings. 10. The stent of claim 1 , wherein the cover occludes the scaffolding openings and prevents tissue ingrowth into a lumen of the stent. 11. The stent of claim 1 , wherein the scaffolding comprises a braided mesh of filaments. 12. The stent of claim 11 , wherein at least one of the filaments extending through the second portion is exposed from the cover. 13. The stent of claim 1 , wherein the second portion includes a plurality of controlled tissue ingrowth features, wherein in each controlled tissue ingrowth feature, the outer surface of the cover extends inward and is spaced radially inward away from the inner surface of the scaffolding. 14. The stent of claim 1 , wherein an entirety of the cover has a uniform thickness.

Assignees

Inventors

Classifications

  • the wire-like elements formed as helical or spiral coils · CPC title

  • differing in surface structures · CPC title

  • Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped · CPC title

  • characterised by a net-like or mesh-like structure · CPC title

  • Stent-grafts · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11590008B2 cover?
A tubular prosthesis that includes a scaffolding formed by at least one scaffolding filament; a cover; and at least one controlled ingrowth feature constructed and arranged to abut an inner surface of a lumen wall when the prosthesis is implanted in the body lumen. The controlled ingrowth feature may extend inwards or outwards from the prosthesis outer surface. The controlled ingrowth feature m…
Who is the assignee on this patent?
Boston Scient Scimed Inc
What technology area does this patent fall under?
Primary CPC classification A61F2/848. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Feb 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).